Fluorescence-Guided Spatial Drug Screening in 3D Colorectal Cancer Spheroids

Area of Science:

• Biomedical Engineering
• Cancer Research
• Pharmacology

Background:

• 2D cell cultures poorly mimic cancer, hindering drug development success.
• 3D cultures better represent the tumor microenvironment and drug responses.
• Platinum (IV) compounds offer a less toxic alternative to platinum (II) drugs.

Purpose of the Study:

• To evaluate mitochondria-targeting platinum (IV) complexes in 3D colorectal cancer (CRC) spheroids.
• To develop new 3D staining methods for assessing drug effects on mitochondria.
• To correlate in vitro findings with in vivo efficacy for predicting drug translation.

Main Methods:

• Utilized 3D CRC spheroids to model tumor pathophysiology, including ABCG2 marker expression.
• Developed novel 3D staining protocols to measure real-time mitochondrial membrane potential (ΔΨ) changes.
• Employed a platinum-sensing dye to quantify platinum accumulation in mitochondria.

Main Results:

• 3D CRC spheroids exhibit enhanced chemoresistance marker expression compared to 2D cultures.
• New protocols successfully monitored mitochondrial dysfunction and platinum uptake in 3D models.
• Demonstrated a strong correlation between in vitro results and in vivo compound efficacy.

Conclusions:

• 3D CRC spheroids are a valuable model for assessing platinum compound behavior and predicting clinical success.
• This approach accelerates drug development and improves the translational potential of new chemotherapeutics.
• Mitochondria-targeting Pt(IV) complexes show promise for colorectal cancer treatment.